COMP <GO>
CPIX vs FBIO // ENTERPRISE SCALE & MARKET CAP
Cumberland Pharmaceuticals Inc. (NASDAQ) VS. Fortress Biotech Inc. (NASDAQ) • 15-METRIC TALLY: CPIX 5
— FBIO 4
▲ ENTERPRISE SCALE & MARKET CAP LEADER: FBIO
LAST: $4.31 (+2.13%) • MKT CAP: $63.2M
market-cap
$63.2M
LAST: $1.94 (+0.52%) • MKT CAP: $64.4M
market-cap
$64.4M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CPIX VS. FBIO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CPIX | FBIO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 85.00% | 66.90% | +18.10 | CPIX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -16.40% | -35.00% | +18.60 | CPIX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 7.42% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -6.30% | -60.00% | +53.70 | CPIX | /operating-margins <GO> |
| Net Profit Margin | -6.40% | 58.50% | -64.90 | FBIO | /net-margins <GO> |
| Revenue Growth (YoY) | 17.60% | 9.70% | +7.90 | CPIX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.00% | -1.00 | FBIO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.72 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 5/9 | +2.00 | CPIX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 32.7 | 39.7 | -7.00 | FBIO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $63.2M | $64.4M | -$1.1M | FBIO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CPIX REV | FBIO REV | CPIX GROSS % | FBIO GROSS % | CPIX FCF | FBIO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $44.5M | $63.3M | 85.0% | 66.9% | $4.8M | -$65.8M |
| FY 2024 | $37.9M | $57.7M | 82.6% | 63.8% | -$678.6K | -$80.2M |
| FY 2023 | $39.6M | $84.5M | — | — | $6.1M | -$128.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CPIX // BETA —
FBIO // BETA —